Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies

Published:2015-04 Issue:2 Volume:29 Page:345-353
ISSN:1521-6918
Container-title:Best Practice & Research Clinical Gastroenterology
language:en
Short-container-title:Best Practice & Research Clinical Gastroenterology

Author:

Schweitzer N.,Vogel A.

Publisher

Elsevier BV

Subject

Gastroenterology

Reference87 articles.

1. Descriptive epidemiology of cholangiocarcinoma in Italy;Alvaro;Dig Liver Dis,2010

2. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?;Shaib;J Hepatol,2004

3. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001;West;Br J Cancer,2006

4. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy;Wang;J Clin Oncol,2013

5. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system;Burke;Ann Surg,1998

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses;Journal of Hematology & Oncology;2022-03-28

2. The VEGF expression associated with prognosis in patients with intrahepatic cholangiocarcinoma: a systematic review and meta-analysis;World Journal of Surgical Oncology;2022-02-21

3. The Effect of Shilajit on Carboplatin-induced Thrombocytopenia and Oxidative Stress in Rats;J PHARM NEGAT RESULT;2022

4. Hepatic arterial infusion chemotherapy following simultaneous metallic stent placement and iodine-125 seed strands for advanced cholangiocarcinoma causing malignant obstructive jaundice: a propensity score matching study;Japanese Journal of Radiology;2021-11-02

5. Combining PD-1 Inhibitor with VEGF/VEGFR2 Inhibitor in Chemotherapy: Report of a Patient with End-Stage Cholangiocarcinoma and Review of Literature;Recent Patents on Anti-Cancer Drug Discovery;2021-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3